EssilorLuxottica's consolidated sales for the third quarter of 2024 were 6,437 million euros, which fell 2% short of forecasts and 3% below UBS's expectations. The company's growth at constant exchange rates was recorded at 4.0%, which also lagged behind consensus and UBS forecasts of 5.9% and 6.1%, respectively.

UBS maintains a Buy recommendation for EssilorLuxottica, with an unchanged price target of 232 euros, citing a promising start to the quarter that could bolster the share price. The firm suggests that investors may find reassurance in the fourth-quarter forecasts despite the challenging market conditions. However, the third-quarter figures have raised concerns regarding margin expansion for the second half of 2024.

The third-quarter results have highlighted a slight shortfall in EssilorLuxottica's sales and growth compared to forecasts and expectations. UBS, however, remains optimistic about the company's prospects and maintains a Buy recommendation with an unchanged price target. The firm believes that the promising start to the quarter could positively impact the share price and that the fourth-quarter forecasts may provide reassurance to investors. Nevertheless, there are concerns about margin expansion for the second half of 2024.